Skip to content

ELVN · Enliven Therapeutics, Inc.

Healthcare · −5.1% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 6 feeds behind: Insider filings, 4 days, and 5 more · Every feed →

On this page

The market view

Price chart

The interactive ELVN chart (by TradingView) loads here.

Our take

4 rules fired on ELVN

In short: none of these rules has solid or some evidence yet, so they show no clear lean on ELVN.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

All 4 rules
The 0–100 score for ELVN, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on ELVN, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of ELVN. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 24, 2026–Oct 21, 2026 · UTC dates · today is excluded

Insider sales

Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual.

Latest 28 days
1
Earlier median
3
Earlier range
2–3
Distinct filers per 28 daysScale: 0–5
Oct 23, 2025Oct 21, 2026
Earlier periodsLatest 28 daysEarlier median 3Limited or missing history

Who appears in the latest period?

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Jun 17, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 3. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 23, 2025–Nov 19, 2025—Unavailable
Nov 20, 2025–Dec 17, 2025—Unavailable
Dec 18, 2025–Jan 14, 2026—Unavailable
Jan 15, 2026–Feb 11, 2026—Unavailable
Feb 12, 2026–Mar 11, 2026—Unavailable
Mar 12, 2026–Apr 8, 2026—Unavailable
Apr 9, 2026–May 6, 2026—Unavailable
May 7, 2026–Jun 3, 2026—Unavailable
Jun 4, 2026–Jul 1, 20260Partial; excluded
Jul 2, 2026–Jul 29, 20260Within stored history
Jul 30, 2026–Aug 26, 20260Within stored history
Aug 27, 2026–Sep 23, 20260Within stored history
Sep 24, 2026–Oct 21, 2026Latest period0Within stored history
Insider sales · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 3; range: 2–3.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 23, 2025–Nov 19, 2025—Unavailable
Nov 20, 2025–Dec 17, 2025—Unavailable
Dec 18, 2025–Jan 14, 2026—Unavailable
Jan 15, 2026–Feb 11, 2026—Unavailable
Feb 12, 2026–Mar 11, 2026—Unavailable
Mar 12, 2026–Apr 8, 2026—Unavailable
Apr 9, 2026–May 6, 2026—Unavailable
May 7, 2026–Jun 3, 2026—Unavailable
Jun 4, 2026–Jul 1, 20265Partial; excluded
Jul 2, 2026–Jul 29, 20263Within stored history
Jul 30, 2026–Aug 26, 20263Within stored history
Aug 27, 2026–Sep 23, 20262Within stored history
Sep 24, 2026–Oct 21, 2026Latest period1Within stored history
Congress purchases · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 23, 2025–Nov 19, 2025—Unavailable
Nov 20, 2025–Dec 17, 2025—Unavailable
Dec 18, 2025–Jan 14, 2026—Unavailable
Jan 15, 2026–Feb 11, 2026—Unavailable
Feb 12, 2026–Mar 11, 2026—Unavailable
Mar 12, 2026–Apr 8, 2026—Unavailable
Apr 9, 2026–May 6, 2026—Unavailable
May 7, 2026–Jun 3, 2026—Unavailable
Jun 4, 2026–Jul 1, 2026—Unavailable
Jul 2, 2026–Jul 29, 2026—Unavailable
Jul 30, 2026–Aug 26, 2026—Unavailable
Aug 27, 2026–Sep 23, 2026—Unavailable
Sep 24, 2026–Oct 21, 2026Latest period—Unavailable
Congress sales · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 23, 2025–Nov 19, 2025—Unavailable
Nov 20, 2025–Dec 17, 2025—Unavailable
Dec 18, 2025–Jan 14, 2026—Unavailable
Jan 15, 2026–Feb 11, 2026—Unavailable
Feb 12, 2026–Mar 11, 2026—Unavailable
Mar 12, 2026–Apr 8, 2026—Unavailable
Apr 9, 2026–May 6, 2026—Unavailable
May 7, 2026–Jun 3, 2026—Unavailable
Jun 4, 2026–Jul 1, 2026—Unavailable
Jul 2, 2026–Jul 29, 2026—Unavailable
Jul 30, 2026–Aug 26, 2026—Unavailable
Aug 27, 2026–Sep 23, 2026—Unavailable
Sep 24, 2026–Oct 21, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Owners & lobbying

All 37 records in this snapshot
  1. Filed
  2. Filed
  3. Filed
  4. Disclosed
    J. Scott Garland · Sale

    Transaction dated Oct 1, 2026

  5. Filed
  6. Disclosed
    Benjamin Hohl · Sale

    Transaction dated Sep 17, 2026

  7. Disclosed
    Benjamin Hohl · Sale

    Transaction dated Sep 17, 2026

  8. Disclosed
    Benjamin Hohl · Sale

    Transaction dated Sep 17, 2026

  9. Disclosed
    Helen Louise Collins · Sale

    Transaction dated Sep 17, 2026

  10. Disclosed
    Helen Louise Collins · Sale

    Transaction dated Sep 17, 2026

  11. Disclosed
    Helen Louise Collins · Sale

    Transaction dated Sep 17, 2026

  12. Filed
  13. Filed
  14. Disclosed
    Benjamin Hohl · Sale

    Transaction dated Aug 17, 2026

  15. Disclosed
    Benjamin Hohl · Sale

    Transaction dated Aug 17, 2026

  16. Disclosed
    Helen Louise Collins · Sale

    Transaction dated Aug 17, 2026

  17. Disclosed
    Helen Louise Collins · Sale

    Transaction dated Aug 17, 2026

  18. Disclosed
    Mika K Derynck · Sale

    Transaction dated Aug 4, 2026

  19. Filed
  20. Disclosed
    Benjamin Hohl · Sale

    Transaction dated Jul 17, 2026

  21. Disclosed
    Benjamin Hohl · Sale

    Transaction dated Jul 17, 2026

  22. Disclosed
    Benjamin Hohl · Sale

    Transaction dated Jul 17, 2026

  23. Disclosed
    Benjamin Hohl · Sale

    Transaction dated Jul 17, 2026

  24. Disclosed
    Benjamin Hohl · Sale

    Transaction dated Jul 17, 2026

  25. Disclosed
    Helen Louise Collins · Sale

    Transaction dated Jul 17, 2026

  26. Disclosed
    Helen Louise Collins · Sale

    Transaction dated Jul 17, 2026

  27. Disclosed
    Helen Louise Collins · Sale

    Transaction dated Jul 17, 2026

  28. Disclosed
    Helen Louise Collins · Sale

    Transaction dated Jul 17, 2026

  29. Disclosed
    Helen Louise Collins · Sale

    Transaction dated Jul 17, 2026

  30. Filed
  31. Disclosed
    Lori Anne Kunkel · Sale

    Transaction dated Jul 6, 2026

  32. Disclosed
    Lori Anne Kunkel · Sale

    Transaction dated Jul 6, 2026

  33. Filed
  34. Disclosed
    Orbimed Advisors LLC · Sale

    Transaction dated Jun 22, 2026

  35. Filed
  36. Filed
  37. Filed

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on ELVN disclosed in the last 90 days.

See every Congress trade on ELVN →

Company insiders

0 buys · 8 sells (22 filed lots) · $11.9M sold

  1. ▼ SELLJ. Scott Garland DirectorELVN Enliven Therapeutics, Inc.$607Kdisclosed Oct 5 · filed 4 days after the trade
  2. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$146Kdisclosed Sep 21 · filed 4 days after the trade
  3. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$12.4Kdisclosed Sep 21 · filed 4 days after the trade
  4. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$177Kdisclosed Sep 21 · filed 4 days after the trade
  5. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$111Kdisclosed Sep 21 · filed 4 days after the trade
  6. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$14.9Kdisclosed Sep 21 · filed 4 days after the trade
  7. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$93.5Kdisclosed Sep 21 · filed 4 days after the trade
  8. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$228Kdisclosed Aug 19 · filed 2 days after the trade
  9. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$270Kdisclosed Aug 19 · filed 2 days after the trade
  10. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$65.3Kdisclosed Aug 19 · filed 2 days after the trade
See every insider trade on ELVN →

Filings & events

Company filings (8-K) 60

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Quarterly or yearly results · item 2.0210
  • Directors or officers joined, left or got new pay · item 5.026
  • Shared information with investors · item 7.015
  • Other events · item 8.015
  • Shareholder vote results · item 5.074
  • Signed a major agreement · item 1.013

Filing red flags 15

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

Planned insider sales (Form 144) 149

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

4 in the last 90 days · 149 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 5

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 3 filings
  • 13G, just holds: 2 filings

Filed most: Orbimed Advisors LLC (3) · Vestal Point Capital, LP (1) · Polar Capital Holdings Plc (1)

Biggest named funds (13F)

The largest ELVN holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on ELVN

  1. ▼ SELLJ. Scott Garland DirectorELVN Enliven Therapeutics, Inc.$607Kdisclosed Oct 5 · filed 4 days after the trade
  2. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$146Kdisclosed Sep 21 · filed 4 days after the trade
  3. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$12.4Kdisclosed Sep 21 · filed 4 days after the trade
  4. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$177Kdisclosed Sep 21 · filed 4 days after the trade
  5. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$111Kdisclosed Sep 21 · filed 4 days after the trade
  6. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$14.9Kdisclosed Sep 21 · filed 4 days after the trade
  7. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$93.5Kdisclosed Sep 21 · filed 4 days after the trade
  8. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$228Kdisclosed Aug 19 · filed 2 days after the trade
  9. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$270Kdisclosed Aug 19 · filed 2 days after the trade
  10. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$65.3Kdisclosed Aug 19 · filed 2 days after the trade
  11. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$82.4Kdisclosed Aug 19 · filed 2 days after the trade
  12. ▼ SELLMika K Derynck DirectorELVN Enliven Therapeutics, Inc.$9.6Mdisclosed Aug 6 · filed 2 days after the trade
  13. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$6.6Kdisclosed Jul 21 · filed 4 days after the trade
  14. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$16.2Kdisclosed Jul 21 · filed 4 days after the trade
  15. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$3.4Kdisclosed Jul 21 · filed 4 days after the trade
  16. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$11.6Kdisclosed Jul 21 · filed 4 days after the trade
  17. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$134Kdisclosed Jul 21 · filed 4 days after the trade
  18. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$108Kdisclosed Jul 21 · filed 4 days after the trade
  19. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$23.7Kdisclosed Jul 21 · filed 4 days after the trade
  20. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$117Kdisclosed Jul 21 · filed 4 days after the trade
  21. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$141Kdisclosed Jul 21 · filed 4 days after the trade
  22. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$19Kdisclosed Jul 21 · filed 4 days after the trade
  23. ▼ SELLLori Anne Kunkel DirectorELVN Enliven Therapeutics, Inc.$205Kdisclosed Jul 8 · filed 2 days after the trade
  24. ▼ SELLLori Anne Kunkel DirectorELVN Enliven Therapeutics, Inc.$299Kdisclosed Jul 8 · filed 2 days after the trade
  25. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade
See all 48 trades on ELVN →
People & votes

Which members of Congress traded ELVN, sponsored bills that touch it and voted on them — opens here.